Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Title:
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months
Author:
Haworth, Charles S Shteinberg, Michal Winthrop, Kevin Barker, Alan Blasi, Francesco Dimakou, Katerina Morgan, Lucy C O'Donnell, Anne E Ringshausen, Felix C Sibila, Oriol Thomson, Rachel M Carroll, Kevin J Pontenani, Federica Castellani, Paola Chalmers, James D
Appeared in:
Lancet respiratory medicine
Paging:
Volume 12 () nr. 10 pages 787-798
Year:
2024
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license